Fourpath Capital Management
MDT icon

Fourpath Capital Management’s Medtronic MDT Stock Holding History

Fourpath Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.73M Sell
101,174
-244
-0.2% -$21.5K 1.13% 23
2026
Q2 		$7.93M Buy
101,418
+9,063
+10% +$731K 1.04% 26
2026
Q1 		$8M Buy
92,355
+4,643
+5% +$445K 1.15% 20
2025
Q4 		$8.43M Buy
87,712
+69
+0.1% +$6.7K 1.15% 24
2025
Q3 		$8.35M Buy
87,643
+73
+0.1% +$6.71K 1.19% 25
2025
Q2 		$7.63M Buy
87,570
+75
+0.1% +$6.36K 1.2% 19
2025
Q1 		$7.86M Buy
87,495
+80
+0.1% +$7.16K 1.37% 19
2024
Q4 		$6.98M Sell
87,415
-46
-0.1% -$3.98K 1.29% 19
2024
Q3 		$7.87M Buy
+87,461
New +$7.36M 1.45% 15
2024
Q1 		– Sell
-6,852
Closed -$565K – 145
2023
Q4 		$565K Sell
6,852
-276
-4% -$21K 0.38% 56
2023
Q3 		$559K Buy
7,128
+786
+12% +$65.8K 0.42% 60
2023
Q2 		$559K Sell
6,342
-81
-1% -$6.97K 0.67% 46
2023
Q1 		$518K Sell
6,423
-12
-0.2% -$978 0.36% 70
2022
Q4 		$500K Buy
+6,435
New +$522K 0.36% 72
2022
Q1 		– Sell
-2,659
Closed -$275K – 169
2021
Q4 		$275K Buy
+2,659
New +$308K 0.11% 129

Other funds holding MDT

Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Gradient Investments
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
Matrix Asset Advisors
Matrix Asset Advisors White Plains, New York $1.21B AUM 19.26% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Fourpath Capital Management's MDT Position: Q3 2026 in Review

Fourpath Capital Management reduced its Medtronic (MDT) stake by 0.24% in Q3 2026, selling an estimated $21.5K and leaving 101,174 shares worth $8.73M. The position accounts for 1.13% of the portfolio, ranked #23.

Fourpath Capital Management first reported a position in MDT in Q4 2021 and has held it in 15 quarters since. 372 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Fourpath Capital Management held 101,174 shares of Medtronic worth $8.73M as of Q3 2026.
  • Fourpath Capital Management sold 244 Medtronic shares in Q3 2026, an estimated $21.5K.
  • Medtronic made up 1.13% of Fourpath Capital Management's portfolio in Q3 2026, its #23 holding.
  • Fourpath Capital Management first reported a position in Medtronic in Q4 2021 and has held it in 15 quarters since.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.